-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $50

Benzinga·11/05/2025 18:39:47
Listen to the news
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $85 to $50.